Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.695 |
Remote Similarity |
NPD2936 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD2315 |
Approved |
0.6859 |
Remote Similarity |
NPD2301 |
Approved |
0.6806 |
Remote Similarity |
NPD3310 |
Approved |
0.6685 |
Remote Similarity |
NPD2662 |
Approved |
0.6685 |
Remote Similarity |
NPD2660 |
Approved |
0.6683 |
Remote Similarity |
NPD5540 |
Phase 2 |
0.6633 |
Remote Similarity |
NPD5757 |
Discontinued |
0.6615 |
Remote Similarity |
NPD1860 |
Approved |
0.6598 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.648 |
Remote Similarity |
NPD2138 |
Approved |
0.648 |
Remote Similarity |
NPD2137 |
Approved |
0.6468 |
Remote Similarity |
NPD2747 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD2807 |
Discontinued |
0.6425 |
Remote Similarity |
NPD1580 |
Clinical (unspecified phase) |
0.6406 |
Remote Similarity |
NPD3418 |
Clinical (unspecified phase) |
0.6396 |
Remote Similarity |
NPD6762 |
Discontinued |
0.6359 |
Remote Similarity |
NPD5013 |
Approved |
0.6341 |
Remote Similarity |
NPD691 |
Discontinued |
0.6335 |
Remote Similarity |
NPD3361 |
Phase 1 |
0.6332 |
Remote Similarity |
NPD5449 |
Clinical (unspecified phase) |
0.6326 |
Remote Similarity |
NPD3854 |
Phase 1 |
0.6318 |
Remote Similarity |
NPD1250 |
Clinical (unspecified phase) |
0.6302 |
Remote Similarity |
NPD1614 |
Discontinued |
0.6298 |
Remote Similarity |
NPD9254 |
Phase 3 |
0.6278 |
Remote Similarity |
NPD1579 |
Discontinued |
0.625 |
Remote Similarity |
NPD3848 |
Phase 2 |
0.6229 |
Remote Similarity |
NPD988 |
Discontinued |
0.6219 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6202 |
Remote Similarity |
NPD2805 |
Phase 2 |
0.6195 |
Remote Similarity |
NPD2362 |
Approved |
0.6193 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.6188 |
Remote Similarity |
NPD4327 |
Phase 1 |
0.6184 |
Remote Similarity |
NPD3338 |
Clinical (unspecified phase) |
0.6169 |
Remote Similarity |
NPD1308 |
Approved |
0.6161 |
Remote Similarity |
NPD4977 |
Approved |
0.6146 |
Remote Similarity |
NPD4909 |
Approved |
0.6143 |
Remote Similarity |
NPD4142 |
Discontinued |
0.6135 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6114 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6109 |
Remote Similarity |
NPD4933 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD2373 |
Clinical (unspecified phase) |
0.6098 |
Remote Similarity |
NPD2774 |
Clinical (unspecified phase) |
0.6091 |
Remote Similarity |
NPD2829 |
Clinical (unspecified phase) |
0.6083 |
Remote Similarity |
NPD3976 |
Clinical (unspecified phase) |
0.6078 |
Remote Similarity |
NPD2728 |
Approved |
0.6078 |
Remote Similarity |
NPD2730 |
Approved |
0.6078 |
Remote Similarity |
NPD2729 |
Approved |
0.6073 |
Remote Similarity |
NPD2401 |
Approved |
0.6073 |
Remote Similarity |
NPD2402 |
Approved |
0.6066 |
Remote Similarity |
NPD3831 |
Approved |
0.6064 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.6056 |
Remote Similarity |
NPD7103 |
Approved |
0.6056 |
Remote Similarity |
NPD5012 |
Phase 2 |
0.6056 |
Remote Similarity |
NPD4446 |
Approved |
0.6052 |
Remote Similarity |
NPD5831 |
Discontinued |
0.6044 |
Remote Similarity |
NPD174 |
Discontinued |
0.6043 |
Remote Similarity |
NPD176 |
Clinical (unspecified phase) |
0.604 |
Remote Similarity |
NPD1887 |
Clinical (unspecified phase) |
0.6039 |
Remote Similarity |
NPD5274 |
Clinical (unspecified phase) |
0.6018 |
Remote Similarity |
NPD5129 |
Phase 3 |
0.6 |
Remote Similarity |
NPD3287 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.5991 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.599 |
Remote Similarity |
NPD2111 |
Clinical (unspecified phase) |
0.5982 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.5981 |
Remote Similarity |
NPD7270 |
Phase 2 |
0.5981 |
Remote Similarity |
NPD5000 |
Phase 2 |
0.5979 |
Remote Similarity |
NPD404 |
Discontinued |
0.5973 |
Remote Similarity |
NPD5468 |
Clinical (unspecified phase) |
0.596 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.5955 |
Remote Similarity |
NPD264 |
Clinical (unspecified phase) |
0.5935 |
Remote Similarity |
NPD6888 |
Discontinued |
0.5931 |
Remote Similarity |
NPD3771 |
Phase 3 |
0.5929 |
Remote Similarity |
NPD4932 |
Clinical (unspecified phase) |
0.5928 |
Remote Similarity |
NPD418 |
Approved |
0.5926 |
Remote Similarity |
NPD9709 |
Approved |
0.5926 |
Remote Similarity |
NPD9708 |
Approved |
0.592 |
Remote Similarity |
NPD676 |
Discontinued |
0.5918 |
Remote Similarity |
NPD1601 |
Approved |
0.5911 |
Remote Similarity |
NPD5493 |
Clinical (unspecified phase) |
0.5901 |
Remote Similarity |
NPD1591 |
Approved |
0.5894 |
Remote Similarity |
NPD2352 |
Approved |
0.5894 |
Remote Similarity |
NPD2324 |
Approved |
0.5888 |
Remote Similarity |
NPD773 |
Approved |
0.5888 |
Remote Similarity |
NPD5495 |
Phase 2 |
0.5882 |
Remote Similarity |
NPD9703 |
Approved |
0.5879 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD5324 |
Clinical (unspecified phase) |
0.5872 |
Remote Similarity |
NPD2295 |
Clinical (unspecified phase) |
0.5871 |
Remote Similarity |
NPD2931 |
Phase 1 |
0.5865 |
Remote Similarity |
NPD6272 |
Phase 1 |
0.5865 |
Remote Similarity |
NPD4892 |
Clinical (unspecified phase) |
0.586 |
Remote Similarity |
NPD6195 |
Clinical (unspecified phase) |
0.5859 |
Remote Similarity |
NPD3232 |
Clinical (unspecified phase) |
0.5854 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.5847 |
Remote Similarity |
NPD544 |
Clinical (unspecified phase) |
0.5842 |
Remote Similarity |
NPD3409 |
Phase 1 |
0.5825 |
Remote Similarity |
NPD5642 |
Approved |
0.5825 |
Remote Similarity |
NPD6047 |
Phase 1 |
0.5823 |
Remote Similarity |
NPD5985 |
Phase 2 |
0.5822 |
Remote Similarity |
NPD1499 |
Phase 3 |
0.5818 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5814 |
Remote Similarity |
NPD6269 |
Clinical (unspecified phase) |
0.5814 |
Remote Similarity |
NPD6268 |
Phase 1 |
0.5812 |
Remote Similarity |
NPD2524 |
Discontinued |
0.5811 |
Remote Similarity |
NPD4447 |
Phase 2 |
0.5805 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.5804 |
Remote Similarity |
NPD3521 |
Phase 2 |
0.5804 |
Remote Similarity |
NPD5533 |
Discontinued |
0.5798 |
Remote Similarity |
NPD3629 |
Approved |
0.5798 |
Remote Similarity |
NPD3630 |
Approved |
0.5794 |
Remote Similarity |
NPD5584 |
Clinical (unspecified phase) |
0.5789 |
Remote Similarity |
NPD2892 |
Phase 1 |
0.5784 |
Remote Similarity |
NPD758 |
Approved |
0.578 |
Remote Similarity |
NPD6328 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD4312 |
Approved |
0.5777 |
Remote Similarity |
NPD3279 |
Phase 2 |
0.5775 |
Remote Similarity |
NPD5467 |
Phase 2 |
0.5771 |
Remote Similarity |
NPD1569 |
Phase 2 |
0.5769 |
Remote Similarity |
NPD6735 |
Approved |
0.5769 |
Remote Similarity |
NPD207 |
Discontinued |
0.5767 |
Remote Similarity |
NPD3855 |
Phase 3 |
0.5765 |
Remote Similarity |
NPD513 |
Approved |
0.5764 |
Remote Similarity |
NPD1167 |
Phase 3 |
0.5762 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.5759 |
Remote Similarity |
NPD5465 |
Phase 2 |
0.5749 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5747 |
Remote Similarity |
NPD5470 |
Clinical (unspecified phase) |
0.5743 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.5743 |
Remote Similarity |
NPD2864 |
Phase 1 |
0.574 |
Remote Similarity |
NPD2318 |
Discontinued |
0.5737 |
Remote Similarity |
NPD2110 |
Approved |
0.5735 |
Remote Similarity |
NPD3460 |
Discontinued |
0.5735 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.5729 |
Remote Similarity |
NPD1857 |
Discontinued |
0.5728 |
Remote Similarity |
NPD1174 |
Phase 2 |
0.5721 |
Remote Similarity |
NPD3941 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD2293 |
Phase 2 |
0.5714 |
Remote Similarity |
NPD6215 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD4155 |
Approved |
0.5714 |
Remote Similarity |
NPD2364 |
Suspended |
0.5708 |
Remote Similarity |
NPD4294 |
Phase 2 |
0.5707 |
Remote Similarity |
NPD2915 |
Discontinued |
0.5707 |
Remote Similarity |
NPD5538 |
Clinical (unspecified phase) |
0.5707 |
Remote Similarity |
NPD509 |
Phase 3 |
0.5707 |
Remote Similarity |
NPD4550 |
Clinical (unspecified phase) |
0.5707 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5702 |
Remote Similarity |
NPD5907 |
Phase 3 |
0.5701 |
Remote Similarity |
NPD1497 |
Phase 3 |
0.57 |
Remote Similarity |
NPD2724 |
Phase 1 |
0.5699 |
Remote Similarity |
NPD945 |
Clinical (unspecified phase) |
0.5693 |
Remote Similarity |
NPD1586 |
Approved |
0.569 |
Remote Similarity |
NPD2400 |
Phase 2 |
0.5689 |
Remote Similarity |
NPD6218 |
Discontinued |
0.5686 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.5686 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.5684 |
Remote Similarity |
NPD1363 |
Phase 3 |
0.5682 |
Remote Similarity |
NPD1367 |
Phase 2 |
0.568 |
Remote Similarity |
NPD4934 |
Approved |
0.5678 |
Remote Similarity |
NPD1215 |
Discontinued |
0.5678 |
Remote Similarity |
NPD1248 |
Discontinued |
0.5677 |
Remote Similarity |
NPD5424 |
Discontinued |
0.5676 |
Remote Similarity |
NPD1468 |
Clinical (unspecified phase) |
0.5674 |
Remote Similarity |
NPD7005 |
Clinical (unspecified phase) |
0.5665 |
Remote Similarity |
NPD5139 |
Phase 1 |
0.5665 |
Remote Similarity |
NPD5104 |
Approved |
0.566 |
Remote Similarity |
NPD4348 |
Clinical (unspecified phase) |
0.5659 |
Remote Similarity |
NPD3652 |
Approved |
0.5659 |
Remote Similarity |
NPD4556 |
Approved |
0.5658 |
Remote Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.5654 |
Remote Similarity |
NPD3261 |
Phase 1 |
0.5654 |
Remote Similarity |
NPD3228 |
Phase 1 |
0.5654 |
Remote Similarity |
NPD6154 |
Approved |
0.5645 |
Remote Similarity |
NPD2139 |
Approved |
0.5644 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.5641 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.564 |
Remote Similarity |
NPD7709 |
Discontinued |
0.5639 |
Remote Similarity |
NPD5419 |
Suspended |
0.5637 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.5634 |
Remote Similarity |
NPD1951 |
Clinical (unspecified phase) |
0.5634 |
Remote Similarity |
NPD5464 |
Approved |
0.5631 |
Remote Similarity |
NPD1708 |
Approved |
0.5631 |
Remote Similarity |
NPD1707 |
Approved |
0.5628 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.5628 |
Remote Similarity |
NPD3889 |
Approved |
0.5625 |
Remote Similarity |
NPD7277 |
Approved |
0.5625 |
Remote Similarity |
NPD7276 |
Approved |
0.5622 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5622 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.5622 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5619 |
Remote Similarity |
NPD7504 |
Discontinued |
0.5616 |
Remote Similarity |
NPD6229 |
Phase 2 |
0.5614 |
Remote Similarity |
NPD5884 |
Clinical (unspecified phase) |
0.5613 |
Remote Similarity |
NPD1896 |
Approved |
0.5612 |
Remote Similarity |
NPD4326 |
Phase 2 |
0.5611 |
Remote Similarity |
NPD7895 |
Discontinued |
0.5611 |
Remote Similarity |
NPD2357 |
Approved |
0.561
|
Remote Similarity |
NPD1587 |
Approved |